No Data
No Data
Purple Biotech to Present at 2025 AACR Meeting
Express News | Purple Biotech To Present CM24 And NT219 Data For Pancreatic, Colorectal, And Head And Neck Cancers At 2025 AACR Meeting
Purple Biotech Unveils Updated Oncology Pipeline Progress
Purple Biotech | 20-F: FY2024 Annual Report
Purple Biotech | 6-K/A: Report of foreign private issuer (related to financial reporting)
Purple Biotech Sees Cash Runway Into Mid-2026